We use cookies in order to provide you with a user-friendly and effective service as well as content adapted to your interests. We also use cookies to dynamically display Univadis ads and ads from our business partners on both Univadis and selected third party websites. By clicking or navigating the site, you agree to this use.
Manage preferences. Learn more.

Univadis - a service form MSD

A trusted medical reference

Create an account Log in

app catalog Search

Log in

Close

My Account

Loading...

Medical News Medical Quiz Conference Reports Delete Radiology Collection Delete Link Library PubMed Delete Explore
new apps

See all my apps Hide my apps

Explore new apps Manage my apps

Rearrange your apps by dragging them or delete them with the cross.

Save Cancel

Welcome. Please log in or create an account.

Log in

Remember me (Uncheck if on a shared computer)

Forgot your Password ?

Please review the fields marked in red and resubmit the form

Create an account

Register to access independent medical news and resources from Univadis^®

Latest updates

Medical News

A prospective observational cohort study of 1,171 patients with previously untreated locally advanced or metastatic colorectal cancer.

Coffee intake linked with improved survival in advanced or metastatic colorectal cancer

Univadis Medical News
Wednesday 23 September 2020

A prospective observational cohort study of 1,171 patients with previously untreated locally advanced or metastatic colorectal cancer.

These adverse events carry high risks for severe outcomes including death, even with standard doses of the drugs.

Heart-related side effects of hydroxychloroquine and chloroquine

Univadis Medical News
Wednesday 23 September 2020

These adverse events carry high risks for severe outcomes including death, even with standard doses of the drugs.

The European Medicines Agency has approved a new indication for sucroferric oxyhydroxide.

New treatment for children with chronic kidney disease

Univadis Medical News
Wednesday 23 September 2020

The European Medicines Agency has approved a new indication for sucroferric oxyhydroxide.

More Medical News >

Conference Reports

ACOG: The effect of operative time on perioperative morbidity after laparoscopic hysterectomy

Conference reports - RSi Communications
Thursday 01 May 2014

a direct, independent correlation between increased operative time during laparoscopic hysterectomy and perioperative morbidity

More Conference Reports >

Featured channels

application icon

Oncology Oncology essentials all in one place

About Univadis^®

Univadis^® provided by Aptus Health, brings you unbiased, relevant medical news as well as helpful resources for your daily practice at no cost.

Our Partners

Univadis^® brings together premium content publishers that deliver comprehensive and up-to-date medical information.

Contact Us

E-mail Us

Complete contact form >

Aptus Health does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-Aptus Health sources. Please read our Terms of Use for more information

Terms of Use | Privacy Policy

©2020 Aptus Health, Inc. All rights reserved.